Longitudinal Outcomes of Dolutegravir-Based Antiretroviral Therapy in a Large Nigerian Programmatic HIV-1 Cohort, 2017–2019

Adam Abdullahi, Edun Martin, Asare Kwabena, Haruna Wisso Abdullahi, Ibrahim Musa Kida, Sophia Osawe, James Onyemata, Sani H Aliyu, Manhattan Charurat, Fatima-Murtala Ibrahim, Victor Adamu, Helen Omuh, Tim Efuntoye, Patrick Dakum, Alash’le Abimiku, Ravindra K Gupta

Open source

DOI
10.1093/ofid/ofag549
Published
2026-08-28
Container
Open Forum Infectious Diseases
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ofid/ofag549,
  title = {Longitudinal Outcomes of Dolutegravir-Based Antiretroviral Therapy in a Large Nigerian Programmatic HIV-1 Cohort, 2017–2019},
  author = {Adam Abdullahi and Edun Martin and Asare Kwabena and Haruna Wisso Abdullahi and Ibrahim Musa Kida and Sophia Osawe and James Onyemata and Sani H Aliyu and Manhattan Charurat and Fatima-Murtala Ibrahim and Victor Adamu and Helen Omuh and Tim Efuntoye and Patrick Dakum and Alash’le Abimiku and Ravindra K Gupta},
  year = {2026},
  journal = {Open Forum Infectious Diseases},
  doi = {10.1093/ofid/ofag549},
  url = {https://doi.org/10.1093/ofid/ofag549}
}

RIS

TY  - JOUR
TI  - Longitudinal Outcomes of Dolutegravir-Based Antiretroviral Therapy in a Large Nigerian Programmatic HIV-1 Cohort, 2017–2019
AU  - Adam Abdullahi
AU  - Edun Martin
AU  - Asare Kwabena
AU  - Haruna Wisso Abdullahi
AU  - Ibrahim Musa Kida
AU  - Sophia Osawe
AU  - James Onyemata
AU  - Sani H Aliyu
AU  - Manhattan Charurat
AU  - Fatima-Murtala Ibrahim
AU  - Victor Adamu
AU  - Helen Omuh
AU  - Tim Efuntoye
AU  - Patrick Dakum
AU  - Alash’le Abimiku
AU  - Ravindra K Gupta
PY  - 2026
JO  - Open Forum Infectious Diseases
DO  - 10.1093/ofid/ofag549
UR  - https://doi.org/10.1093/ofid/ofag549
ER  - 

APA

Abdullahi, A., Martin, E., Kwabena, A., Abdullahi, H. W., Kida, I. M., Osawe, S., Onyemata, J., Aliyu, S. H., Charurat, M., Ibrahim, F., Adamu, V., Omuh, H., Efuntoye, T., Dakum, P., Abimiku, A., & Gupta, R. K. (2026). Longitudinal Outcomes of Dolutegravir-Based Antiretroviral Therapy in a Large Nigerian Programmatic HIV-1 Cohort, 2017–2019. Open Forum Infectious Diseases. https://doi.org/10.1093/ofid/ofag549

Source records